Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Staten Island › NPI 1477792232
Physician

Spine and Pain Consultant, PLLC

Spine and Pain Consultant, PLLC was paid $1.24M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 51% of everything it billed.

33Billing provider infoSPINE AND PAIN CONSULTANT, PLLC
STATEN ISLAND, NY 10305
33aNPI1477792232assigned 02/18/2009
28Total paid$1.24M
24GClaims46,694
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pain Medicine (Anesthesiology) Physician providers in New York

Rank by total paid#9 of 125
Median peer was paid$14K
This provider vs. median89×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,553$120K
20193,451$151K
20203,529$134K
20213,402$156K
20229,356$224K
202313,227$234K
2024incomplete11,176$225K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 51% 8,137 7,682 $639K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 39% 8,812 8,300 $482K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3.6% 386 378 $44K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.9% 272 271 $24K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1.4% 147 147 $17K
80306 <1% 1,489 1,472 $8K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 44 44 $7K
64493 <1% 24 24 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,722 3,476 $5K
64495 <1% 24 24 $3K
64494 <1% 24 24 $3K
99401 <1% 140 139 $3K
13 more codes
99442 <1% 32 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 22 $634.92
86769 <1% 14 $435.82
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 417 $200.15
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 199 $129.06
81025 <1% 24 $86.35
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications <1% 7,672 $67.78
36415 Collection of venous blood by venipuncture <1% 17 $4.86
G8417 Bmi is documented above normal parameters and a follow-up plan is documented <1% 5,587 $4.84
G9903 Patient screened for tobacco use and identified as a tobacco non-user <1% 4,733 $0.01
G9906 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) <1% 1,279 $0.01
G9902 Patient screened for tobacco use and identified as a tobacco user <1% 1,033 $0.01
1036F 0% 2,444 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHAPMAN, KENNETH (MEDICAL DIRECTOR)
Same official

Other billing entities under CHAPMAN, KENNETH

Full network →
ProviderLocationPaid
Specialty Anesthesia, PLLCStaten Island, NY$46K
Charter Township of HighlandHighland, MI$45K
Richmond Asc LLCStaten Island, NY$12K
Mantro Mobile Imaging LLCWhittier, CA$6K
Mantro Mobile Imaging LLCLas Vegas, NV$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.